Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic alterations in transporters and metformin resistance
2013-003938-32Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of metformin in type 2 diabetes mellitus (T2DM) and polycystic ovary syndrome (PCOS), sponsored by Medical University of Graz. Primary endpoint: Primary endpoint: Metformin concentration in plasma. Started Jan 2014; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on 2013-003938-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003938-32.